Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Medicare Shakeup: Policy Changes Rattle Big Insurers

by Team Lumida
May 17, 2024
in Macro, News
Reading Time: 4 mins read
A A
0
emergency signage

Photo by Pixabay on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Biden administration’s policy changes reduce Medicare Advantage profitability.
  2. Insurers like CVS and Humana face rising costs and declining profits.
  3. Market and regulatory challenges could reshape the future of Medicare Advantage.

What Happened?

The Medicare Advantage landscape has dramatically shifted. Medicare Advantage, a program where the government pays insurers to manage senior care, has been a major profit driver for companies like UnitedHealth Group and Humana. However, the Biden administration’s recent policy changes have altered the payment structures, causing a significant dip in profitability.

CVS Health’s Aetna unit reported a $900 million surge in unexpected medical costs, leading to its largest one-day share drop in nearly 15 years. As a result, CVS shares have plunged 26% this year, equating to a market cap of just over $70 billion—the same amount it paid for Aetna in 2018. Humana and UnitedHealth have also seen their shares drop by over 20% and 16%, respectively.

Why It Matters?

These changes have rattled investors and corporate boards, signaling a shift from growth to profitability in the Medicare Advantage sector. With the government tightening its purse strings and implementing stricter policies, insurers must adapt quickly. CVS plans to exit some markets and cut back on benefits to improve margins.

Thomas Cowhey, CVS Chief Financial Officer, stated, “The goal for next year is margin over membership.” This shift could open opportunities for companies with better profit margins like UnitedHealth to gain market share. However, the regulatory environment remains a tougher challenge, with tighter payment rates and changes in coding patient risk.

What’s Next?

Insurers are now focusing on mitigating rising costs and adapting to new regulations. Expect strategic exits from less profitable markets and reductions in member benefits. Analysts predict Humana, despite expected lower earnings this year, will rebound to $26 per share by 2026. The industry’s lobbying efforts will intensify to influence public and policymaker opinions.

Wendell Potter, a former Cigna executive, highlighted, “Companies will be investing heavily through campaign donations and lobbying.” A potential Donald Trump win in the upcoming presidential elections could favor privatization and benefit Medicare Advantage. Regardless, the sector remains profitable but without the extraordinary gains seen in recent years.

Source: WSJ
Previous Post

Why Bitcoin’s Correlation with Nasdaq Is Skyrocketing

Next Post

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

Recommended For You

VanEck Drops Gemini as Custodian of Its Bitcoin, Ether and Solana ETFs, Leaving Coinbase Custody in Place From About Feb. 16, 2027

by Team Lumida
22 hours ago
Gemini Stock Down 80% From IPO Peak; $753M Valuation Revives Takeover Speculation as Regulatory Licenses Become Acquisition Target

VanEck is ending Gemini’s custody and clearing role on its bitcoin, ether and Solana ETFs, with the change due around Feb. 16, 2027, CoinDesk reported.

Read more

Senate Passes the BAAJA Permitting Bill 62-33, Splitting Democrats, in a Push to Speed Energy and Data-Center Projects

by Team Lumida
22 hours ago

The Senate voted 62-33 on Thursday to pass the BAAJA permitting bill, which now heads to the House with President Donald Trump’s support.

Read more

Gap Cuts Its Full-Year Sales Outlook to Roughly Flat After Flat Comps, but Shares Rise More Than 11% as Old Navy Shows Progress

by Team Lumida
22 hours ago

Gap lowered its full-year sales outlook to roughly flat and cut adjusted EPS guidance, but shares rose more than 11% Friday on signs of an Old Navy turnaround.

Read more

Intuit to Sell Mailchimp to Berkshire-Backed Bending Spoons for $3.68 Billion, Less Than a Third of the $12 Billion It Paid in 2021

by Team Lumida
22 hours ago

Intuit agreed to sell Mailchimp to Bending Spoons for $3.68 billion, less than a third of the $12 billion it paid in 2021, and cut its fiscal 2027...

Read more

TPG and Corpay Agree to Buy Bill Holdings for About $6 Billion, or $63.25 a Share, With Starboard Backing the Deal

by Team Lumida
22 hours ago

TPG will buy a majority stake in Bill and Corpay a minority interest in a deal valued at about $6 billion, or $63.25 a share, the Wall Street...

Read more

Fed Governor Lisa Cook Says Inflation Has Been Above Target for More Than Five and a Half Years and Warns Against Waiting to Hike

by Team Lumida
22 hours ago

Lisa Cook said Friday that inflation has been above target for more than five and a half years and that waiting to raise rates risks larger increases later.

Read more

Gold Falls 2.81% to $3,520, Heading for Its Worst Week in Eight Months, Down About 8.9%, as Rate-Hike Bets Overwhelm Haven Demand

by Team Lumida
22 hours ago

Spot gold fell 2.81% to $3,520.05 on Friday, on track for its worst week in eight months, down about 8.9%, as December Fed hike bets weighed on bullion.

Read more

Treasury Yields Tumble, With the 10-Year Down 12 Basis Points to 4.932%, as Investors Flee to Havens Ahead of a Likely December Fed Hike

by Team Lumida
22 hours ago

The 10-year Treasury yield fell 12 basis points to 4.932% and the 2-year dropped more than 14 basis points to 4.634% as stocks sold off on Friday.

Read more

Bitcoin Breaks $60,000 in the U.S. Session and Later Friday Sinks Below $57,000, Its Lowest Since September 2024

by Team Lumida
22 hours ago

Bitcoin fell below $60,000 in U.S. hours and later Friday sank below $57,000, its lowest since September 2024, as crypto liquidations hit $2.4 billion.

Read more

Nvidia Plunges 14%, Completing Its Longest Weekly Losing Streak Since 2008, After a Report the SEC Is Exploring Accounting Issues

by Team Lumida
22 hours ago

Nvidia fell 14% on Friday and closed lower for a seventh straight week, its longest streak since 2008, after Reuters reported an SEC accounting probe.

Read more
Next Post
woman with face mask holding an alcohol bottle

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Bitcoin Whipsaws After Briefly Crashing 50% From Peak, Traders Eye $60K “Line in the Sand”

February 6, 2026
a person flying through the air on a cloudy day

Is a Recession Really Looming? Here’s What You Need to Know

August 6, 2024
red and blue light streaks

Wall Street Wins Back M&A Debt from Private Credit

September 23, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018